Adenosine A2B receptor signalling is altered by stimulation of bradykinin or interleukin receptors in astroglioma cells
- 31 July 1994
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 25 (1) , 99-102
- https://doi.org/10.1016/0197-0186(94)90060-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclaseCellular Signalling, 1993
- Modification of a Competitive Protein Binding Assay for Determination of Inositol 1,4,5-TrisphosphateAnalytical Biochemistry, 1993
- Bradykinin inhibition of cyclic AMP accumulation in D384 astrocytoma cells. Evidence against a role of cyclic GMPNeurochemistry International, 1992
- Neuroprotective role of adenosine in cerebral ischaemiaTrends in Pharmacological Sciences, 1992
- Adenosine receptor‐induced cAMP changes in D384 astrocytoma cells and the effect of bradykinin thereonActa Physiologica Scandinavica, 1992
- Interleukin-1 and interleukin-1 antagonismBlood, 1991
- Co-existence between receptors, carriers, and second messengers on astrocytes grown in primary culturesNeurochemical Research, 1989